Icu Medical — Q1 2025 Earnings Presentation

4 slides from Icu Medical's earnings presentation, May 8, 2025

Slide 1: ICU Medical, Inc Q1 2025 Conference Call Presentation
ICU Medical, Inc Q1 2025 Conference Call Presentation May 8, 2025 1
Slide 2: Disclosures
Disclosures > Any statement concerning Management’s expectation with respect to future results is a forward-looking statement based upon the best information currently available to Management and assumptions Management believes are reasonable, but Management does not intend the statement to be a rep
Slide 3: 2024 – 2025 Adjusted Revenue
2024 – 2025 Adjusted Revenue In $ Millions 2024 2024 2024 2024 2024 2025 Tracheostomy Q1 Q2 Q3 Q4 Total Q1 Consumables 244 262 265 268 1,039 266 Vascular Access YoY Growth 3% 10% 9% 6% 7% 9% YoY Growth (FXN) 3% 11% 9% 6% 7% 10% Oncology Syringe Systems 157 164 160 172 652 166 YoY Growth -3% 7% 7% 4%
Slide 4: 2025 Guidance and Modeling Assumptions
2025 Guidance and Modeling Assumptions In $ Millions, except per share amounts 4